Selecta Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
Selecta Biosciences, Inc. Earnings Date And Information
Selecta Biosciences, Inc. last posted its earnings results on Thursday, November 2nd, 2023. The company reported $-0.01 earnings per share for the quarter, topping analysts' consensus estimates of $-0.07 by $0.06. The company had revenue of 6.55 M for the quarter and had revenue of 0 for the year. Selecta Biosciences, Inc. has generated $0 earnings per share over the last year ($-0.0014 diluted earnings per share) and currently has a price-to-earnings ratio of -6.69. Selecta Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 12th, 2023 based on prior year's report dates.
Selecta Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2023 | Q3 2023 | -$0.06 | $9.70 M | $6.55 M | ||
| 08/17/2023 | Q2 2023 | -$0.09 | -$0.07 | 0.02 | $5.25 M | |
| 05/04/2023 | Q1 2023 | -$0.08 | -$0.17 | -0.09 | $5.94 M | |
| 03/02/2023 | Q4 2022 | -$0.01 | $0.03 | 0.04 | $16.80 M | |
| 11/03/2022 | Q3 2022 | -$0.00 | -$0.05 | -0.05 | $20.71 M | |
| 08/08/2022 | Q2 2022 | $0.06 | $39.27 M | |||
| 05/05/2022 | Q1 2022 | -$0.09 | $0.23 | 0.32 | $34.00 M | |
| 03/10/2022 | Q4 2021 | -$0.07 | $0.10 | 0.17 | $29.94 M | |
| 11/09/2021 | Q3 2021 | -$0.07 | -$0.16 | -0.09 | $24.43 M | |
| 08/12/2021 | Q2 2021 | -$0.09 | $0.04 | 0.13 | $19.66 M | |
| 05/13/2021 | Q1 2021 | -$0.12 | -$0.22 | -0.1 | $11.05 M | |
| 03/12/2021 | Q4 2020 | -$0.14 | $11.95 M | |||
| 11/05/2020 | Q3 2020 | -$0.12 | -$0.09 | 0.03 | $4.65 M | |
| 08/06/2020 | Q2 2020 | $0.32 | -$0.25 | -0.57 | $0 | |
| 05/07/2020 | Q1 2020 | -$0.27 | -$0.21 | 0.06 | $0 | |
| 03/12/2020 | Q4 2019 | -$0.19 | -$0.28 | -0.09 | $6.65 M | |
| 11/08/2019 | Q3 2019 | -$0.28 | -$0.26 | 0.02 | $0 | |
| 08/08/2019 | Q2 2019 | -$0.34 | -$0.37 | -0.03 | $13,000 | |
| 05/09/2019 | Q1 2019 | -$0.37 | -$0.31 | 0.06 | $10,000 | |
| 03/15/2019 | Q4 2018 | -$0.76 | -$0.65 | 0.11 | $903,000 |
Selecta Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Selecta Biosciences, Inc.'s earnings date?
Selecta Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 12th, 2023 based off last year's report dates.
-
Did Selecta Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Selecta Biosciences, Inc. (:SELB) reported $-0.01 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.07 by $0.06.
-
How can I listen to Selecta Biosciences, Inc.'s earnings conference call?
The conference call for Selecta Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Selecta Biosciences, Inc.'s conference call transcript?
The conference call transcript for Selecta Biosciences, Inc.'s latest earnings report can be read online.
-
How much profit does Selecta Biosciences, Inc. generate each year?
Selecta Biosciences, Inc. (:SELB) has a recorded net income of $0. Selecta Biosciences, Inc. has generated $-0.0014 earnings per share over the last four quarters.
-
What is Selecta Biosciences, Inc.'s price-to-earnings ratio?
Selecta Biosciences, Inc. (:SELB) has a price-to-earnings ratio of -6.69 and price/earnings-to-growth ratio is 1.74.
